The Race for Quantum Supremacy Enters a New Phase
As tech giants and startups vie for dominance in quantum computing, the implications for cybersecurity, drug discovery, and artificial intelligence become increasingly profound.
جزء من The Quantum Decade

For nearly a decade, quantum computing has lived primarily in research labs and theoretical papers. That changed this quarter, when three competing teams independently demonstrated error-corrected operations sustained for longer than the underlying qubit decoherence time — a milestone the field had been chasing since the late 2010s.
What separates this phase from the last is not raw qubit count. The leading systems still operate in the low hundreds of physical qubits. The shift is that those qubits are now reliable enough, for long enough, to run algorithms that produce results researchers can verify against classical hardware. That sounds modest. In practice, it means quantum computers have stopped being demonstrations and started becoming tools.
The cryptographic implications are the most discussed but the least immediate. The post-quantum cryptography standards finalized by NIST last year were designed for exactly this transition; the open question is how quickly enterprise infrastructure will adopt them.
More interesting in the near term are the chemistry applications. Pharmaceutical labs are already using small-scale quantum simulators to model molecular interactions that classical methods approximate poorly. The first FDA submissions referencing quantum-assisted drug design are expected within eighteen months.
What remains stubbornly hard is general-purpose programming. The current generation of quantum hardware demands algorithms written specifically for its physics. The dream of a high-level quantum programming language that abstracts those details — the way C abstracts away CPU registers — is, by most accounts, still a decade out.
